Blueshift Asset Management’s Haemonetics HAE Stock Holding History

Blueshift Asset Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,635	Closed	-$617K	–	956
2021 Q4	$617K	Buy	+11,635	New	+$709K	0.05%	410
2021 Q3	–	Sell	-9,264	Closed	-$617K	–	1117
2021 Q2	$617K	Buy	+9,264	New	+$656K	0.03%	501
2020 Q4	–	Sell	-7,675	Closed	-$670K	–	764
2020 Q3	$670K	Buy	+7,675	New	+$671K	0.09%	286
2020 Q1	–	Sell	-9,305	Closed	-$1.07M	–	403
2019 Q4	$1.07M	Buy	+9,305	New	+$1.13M	0.12%	261
2019 Q2	–	Sell	-2,797	Closed	-$245K	–	805
2019 Q1	$245K	Buy	+2,797	New	+$254K	0.03%	583

Other funds holding HAE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

LCP

LGT Capital Partners Pfaeffikon, Switzerland $1.97B AUM 15.72% 1-Year Est. Return

Blueshift Asset Management's HAE Position: Q1 2022 in Review

Blueshift Asset Management sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 11,635 shares — an estimated $617K sold.

Blueshift Asset Management first reported a position in HAE in Q1 2019 and held it in 5 quarters. The position peaked at $1.07M in Q4 2019. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

Blueshift Asset Management reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
Blueshift Asset Management sold 11,635 Haemonetics shares in Q1 2022, an estimated $617K.
Blueshift Asset Management first reported a position in Haemonetics in Q1 2019 and held it in 5 quarters.
Blueshift Asset Management's Haemonetics position peaked at $1.07M in Q4 2019.
242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Blueshift Asset Management's 13F filing for Q1 2022, filed 12 May 2022.